Sudhanshu P Raikwar

Dr. Sudhanshu P Raikwar

Department of Translational Neuroscience, Barrow Neurological Institute and St. Joseph’s Hospital and Medical Center, Phoenix, AZ 85013, USA
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2017 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
KDKempuraj Duraisamy
Kempuraj Duraisamy
RTRamasamy Thangavel
Ramasamy Thangavel
GSGovindhasamy P. Selvakumar
Govindhasamy P. Selvakumar
SZSmita Zaheer
Smita Zaheer
MAMohammad E. Ahmed
Mohammad E. Ahmed
AZAsgar Zaheer
Asgar Zaheer
Neuroinflammatory response is primarily a protective mechanism in the brain. However, excessive and chronic inflammatory responses can lead to deleterious effects involving immune cells, brain cells and signaling molecules. Neuroinflammation induces and accelerates pathogenesis of Parkinson’s disease (PD), Alzheimer’s disease (AD) and Multiple Sclerosis. Neuroinflammatory pathways are indicated as novel therapeutic targets for these diseases. Mast cells are immune cells of hematopoietic origin that regulate inflammation and upon activation release many proinflammatory mediators in systemic and central nervous system inflammatory conditions. In addition, inflammatory mediators released from activated glial cells induce neurodegeneration in the brain. Systemic inflammation-derived proinflammatory cytokines/chemokines and other factors cause a breach in the blood brain-barrier (BBB) thereby allowing for the entry of immune/inflammatory cells including mast cell progenitors, mast cells and proinflammatory cytokines and chemokines into the brain. These peripheral-derived factors and intrinsically generated cytokines/chemokines, α-synuclein, corticotropin-releasing hormone, substance P, beta amyloid 1-42 (Aβ1-42) peptide and amyloid precursor proteins can activate glial cells, T-cells and mast cells in the brain can induce additional release of inflammatory and neurotoxic molecules contributing to chronic neuroinflammation and neuronal death. The glia maturation factor, a proinflammatory protein discovered in our laboratory released from glia, activates mast cells to release inflammatory cytokines and chemokines. Chronic increase in the proinflammatory mediators induces neurotoxic Aβ and plaque formation in AD brains and neurodegeneration in PD brains. Glial cells, mast cells and T-cells can reactivate each other in neuroinflammatory conditions in the brain and augment neuroinflammation. Further, inflammatory mediators from the brain can also enter into the peripheral system through defective BBB, recruit immune cells into the brain, and exacerbate neuroinflammation. We suggest that mast cell-associated inflammatory mediators from systemic inflammation and brain could augment neuroinflammation and neurodegeneration in the brain. This review addresses the role of some atypical inflammatory mediators that are associated with mast cell inflammation and their activation of glial cells to induce neurodegeneration.

19 February 2019 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
KDKempuraj Duraisamy
Kempuraj Duraisamy
SMShireen Mentor
Shireen Mentor
RTRamasamy Thangavel
Ramasamy Thangavel
MAMohammad E. Ahmed
Mohammad E. Ahmed
GSGovindhasamy Pushpavathi Selvakumar
Govindhasamy Pushpavathi Selvakumar
AZAsgar Zaheer
Asgar Zaheer
Mast cell activation plays an important role in stress-mediated disease pathogenesis. Chronic stress cause or exacerbate aging and age-dependent neurodegenerative diseases. The severity of inflammatory diseases is worsened by the stress. Mast cell activation-dependent inflammatory mediators augment stress associated pain and neuroinflammation. Stress is the second most common trigger of headache due to mast cell activation. Alzheimer’s disease (AD) is a progressive irreversible neurodegenerative disease that affects more women than men and woman’s increased susceptibility to chronic stress could increase the risk for AD. Modern life-related stress, social stress, isolation stress, restraint stress, early life stress are associated with an increased level of neurotoxic beta amyloid (Aβ) peptide. Stress increases cognitive dysfunction, generates amyloid precursor protein (APP), hyperphosphorylated tau, neurofibrillary tangles (NFTs), and amyloid plaques (APs) in the brain. Stress-induced Aβ persists for years and generates APs even several years after the stress exposure. Stress activates hypothalamic-pituitary adrenal (HPA) axis and releases corticotropin-releasing hormone (CRH) from hypothalamus and in peripheral system, which increases the formation of Aβ, tau hyperphosphorylation, and blood-brain barrier (BBB) disruption in the brain. Mast cells are implicated in nociception and pain. Mast cells are the source and target of CRH and other neuropeptides that mediate neuroinflammation. Microglia express receptor for CRH that mediate neurodegeneration in AD. However, the exact mechanisms of how stress-mediated mast cell activation contribute to the pathogenesis of AD remains elusive. This mini-review highlights the possible role of stress and mast cell activation in neuroinflammation, BBB, and tight junction disruption and AD pathogenesis.

3 October 2017 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
MAMohammad Ejaz Ahmed
Mohammad Ejaz Ahmed
SIShankar Iyer
Shankar Iyer
RTRamasamy Thangavel
Ramasamy Thangavel
DKDuraisamy Kempuraj
Duraisamy Kempuraj
GSGovindhasamy Pushpavathi Selvakumar
Govindhasamy Pushpavathi Selvakumar
AZAsgar Zaheer
Asgar Zaheer
Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by the presence of intracellular neurofibrillary tangles (NFTs) containing hyperphosphorylated tau, and the extracellular deposition of amyloid plaques (APs) with misfo

12 December 2017 in Frontiers in Neuroscience
Verified
Journal Article
Open access
KDKempuraj Duraisamy
Kempuraj Duraisamy
GSGovindhasamy P. Selvakumar
Govindhasamy P. Selvakumar
RTRamasamy Thangavel
Ramasamy Thangavel
MAMohammad E. Ahmed
Mohammad E. Ahmed
SZSmita Zaheer
Smita Zaheer
AZAsgar Zaheer
Asgar Zaheer
Mast cells are localized throughout the body and mediate allergic, immune, and inflammatory reactions. They are heterogeneous, tissue-resident, long-lived, and granulated cells. Mast cells increase their numbers in specific site in the body by proliferation, increased recruitment, increased survival, and increased rate of maturation from its progenitors. Mast cells are implicated in brain injuries, neuropsychiatric disorders, stress, neuroinflammation, and neurodegeneration. Brain mast cells are the first responders before microglia in the brain injuries since mast cells can release prestored mediators. Mast cells also can detect amyloid plaque formation during Alzheimer's disease (AD) pathogenesis. Stress conditions activate mast cells to release prestored and newly synthesized inflammatory mediators and induce increased blood-brain barrier permeability, recruitment of immune and inflammatory cells into the brain and neuroinflammation. Stress induces the release of corticotropin-releasing hormone (CRH) from paraventricular nucleus of hypothalamus and mast cells. CRH activates glial cells and mast cells through CRH receptors and releases neuroinflammatory mediators. Stress also increases proinflammatory mediator release in the peripheral systems that can induce and augment neuroinflammation. Post-traumatic stress disorder (PTSD) is a traumatic-chronic stress related mental dysfunction. Currently there is no specific therapy to treat PTSD since its disease mechanisms are not yet clearly understood. Moreover, recent reports indicate that PTSD could induce and augment neuroinflammation and neurodegeneration in the pathogenesis of neurodegenerative diseases. Mast cells play a crucial role in the peripheral inflammation as well as in neuroinflammation due to brain injuries, stress, depression, and PTSD. Therefore, mast cells activation in brain injury, stress, and PTSD may accelerate the pathogenesis of neuroinflammatory and neurodegenerative diseases including AD. This review focusses on how mast cells in brain injuries, stress, and PTSD may promote the pathogenesis of AD. We suggest that inhibition of mast cells activation and brain cells associated inflammatory pathways in the brain injuries, stress, and PTSD can be explored as a new therapeutic target to delay or prevent the pathogenesis and severity of AD.

26 September 2017 in Journal of Neuroimmune Pharmacology
Verified
Journal Article
Closed access
PDF file
DKDuraisamy Kempuraj
Duraisamy Kempuraj
GSGovindhasamy Pushpavathi Selvakumar
Govindhasamy Pushpavathi Selvakumar
SZSmita Zaheer
Smita Zaheer
RTRamasamy Thangavel
Ramasamy Thangavel
MAMohammad Ejaz Ahmed
Mohammad Ejaz Ahmed
AZAsgar Zaheer
Asgar Zaheer

18 June 2018 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
KDKempuraj Duraisamy
Kempuraj Duraisamy
RTRamasamy Thangavel
Ramasamy Thangavel
GSGvindhasamy Pushpavathi Selvakumar
Gvindhasamy Pushpavathi Selvakumar
MAMohammad Ejaz Ahmed
Mohammad Ejaz Ahmed
SZSmita Zaheer
Smita Zaheer
AZAsgar Zaheer
Asgar Zaheer